Selected research
Market Structure
Global Sacral Neuromodulation Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sacral Neuromodulation Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sacral Neuromodulation Device include Axonics (Boston Scientific), Neuspera, General Stim (Nurotron), Medtronic and PINS Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sacral Neuromodulation Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sacral Neuromodulation Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sacral Neuromodulation Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sacral Neuromodulation Device market size, projected growth trends, production technologies, key applications, and end-use industries.
Sacral Neuromodulation Device Segment by Company
Axonics (Boston Scientific)
Neuspera
General Stim (Nurotron)
Medtronic
PINS Medical
Sacral Neuromodulation Device Segment by Type
Rechargeable
Recharge-free
Sacral Neuromodulation Device Segment by Application
Hospitals
ASCs
Sacral Neuromodulation Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sacral Neuromodulation Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sacral Neuromodulation Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sacral Neuromodulation Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sacral Neuromodulation Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sacral Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sacral Neuromodulation Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sacral Neuromodulation Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Rechargeable
- Recharge-free
Applications
- Hospitals
- ASCs
Companies covered
- Axonics (Boston Scientific)
- Neuspera
- General Stim (Nurotron)
- Medtronic
- PINS Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sacral Neuromodulation Device Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sacral Neuromodulation Device Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sacral Neuromodulation Device Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sacral Neuromodulation Device Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sacral Neuromodulation Device Market Dynamics
- 2.1 Sacral Neuromodulation Device Industry Trends
- 2.2 Sacral Neuromodulation Device Industry Drivers
- 2.3 Sacral Neuromodulation Device Industry Opportunities and Challenges
- 2.4 Sacral Neuromodulation Device Industry Restraints
3 Sacral Neuromodulation Device Market by Manufacturers
- 3.1 Global Sacral Neuromodulation Device Revenue by Manufacturers (2021-2026)
- 3.2 Global Sacral Neuromodulation Device Sales by Manufacturers (2021-2026)
- 3.3 Global Sacral Neuromodulation Device Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sacral Neuromodulation Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sacral Neuromodulation Device Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sacral Neuromodulation Device Manufacturers, Product Type & Application
- 3.7 Global Sacral Neuromodulation Device Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sacral Neuromodulation Device Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sacral Neuromodulation Device Players Market Share by Revenue in 2025
- 3.8.3 2025 Sacral Neuromodulation Device Tier 1, Tier 2, and Tier 3
4 Sacral Neuromodulation Device Market by Type
- 4.1 Sacral Neuromodulation Device Type Introduction
- 4.1.1 Rechargeable
- 4.1.2 Recharge-free
- 4.2 Global Sacral Neuromodulation Device Sales by Type
- 4.2.1 Global Sacral Neuromodulation Device Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sacral Neuromodulation Device Sales by Type (2021-2032)
- 4.2.3 Global Sacral Neuromodulation Device Sales Market Share by Type (2021-2032)
- 4.3 Global Sacral Neuromodulation Device Revenue by Type
- 4.3.1 Global Sacral Neuromodulation Device Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sacral Neuromodulation Device Revenue by Type (2021-2032)
- 4.3.3 Global Sacral Neuromodulation Device Revenue Market Share by Type (2021-2032)
5 Sacral Neuromodulation Device Market by Application
- 5.1 Sacral Neuromodulation Device Application Introduction
- 5.1.1 Hospitals
- 5.1.2 ASCs
- 5.2 Global Sacral Neuromodulation Device Sales by Application
- 5.2.1 Global Sacral Neuromodulation Device Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sacral Neuromodulation Device Sales by Application (2021-2032)
- 5.2.3 Global Sacral Neuromodulation Device Sales Market Share by Application (2021-2032)
- 5.3 Global Sacral Neuromodulation Device Revenue by Application
- 5.3.1 Global Sacral Neuromodulation Device Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sacral Neuromodulation Device Revenue by Application (2021-2032)
- 5.3.3 Global Sacral Neuromodulation Device Revenue Market Share by Application (2021-2032)
6 Global Sacral Neuromodulation Device Sales by Region
- 6.1 Global Sacral Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sacral Neuromodulation Device Sales by Region (2021-2032)
- 6.2.1 Global Sacral Neuromodulation Device Sales by Region (2021-2026)
- 6.2.2 Global Sacral Neuromodulation Device Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sacral Neuromodulation Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sacral Neuromodulation Device Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sacral Neuromodulation Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sacral Neuromodulation Device Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sacral Neuromodulation Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sacral Neuromodulation Device Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sacral Neuromodulation Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sacral Neuromodulation Device Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sacral Neuromodulation Device Revenue by Region
- 7.1 Global Sacral Neuromodulation Device Revenue by Region
- 7.1.1 Global Sacral Neuromodulation Device Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sacral Neuromodulation Device Revenue by Region (2021-2026)
- 7.1.3 Global Sacral Neuromodulation Device Revenue by Region (2027-2032)
- 7.1.4 Global Sacral Neuromodulation Device Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sacral Neuromodulation Device Revenue (2021-2032)
- 7.2.2 North America Sacral Neuromodulation Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sacral Neuromodulation Device Revenue (2021-2032)
- 7.3.2 Europe Sacral Neuromodulation Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sacral Neuromodulation Device Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sacral Neuromodulation Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sacral Neuromodulation Device Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sacral Neuromodulation Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Axonics (Boston Scientific)
- 8.1.1 Axonics (Boston Scientific) Company Information
- 8.1.2 Axonics (Boston Scientific) Business Overview
- 8.1.3 Axonics (Boston Scientific) Sacral Neuromodulation Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Axonics (Boston Scientific) Sacral Neuromodulation Device Product Portfolio
- 8.1.5 Axonics (Boston Scientific) Recent Developments
- 8.2 Neuspera
- 8.2.1 Neuspera Company Information
- 8.2.2 Neuspera Business Overview
- 8.2.3 Neuspera Sacral Neuromodulation Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Neuspera Sacral Neuromodulation Device Product Portfolio
- 8.2.5 Neuspera Recent Developments
- 8.3 General Stim (Nurotron)
- 8.3.1 General Stim (Nurotron) Company Information
- 8.3.2 General Stim (Nurotron) Business Overview
- 8.3.3 General Stim (Nurotron) Sacral Neuromodulation Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 General Stim (Nurotron) Sacral Neuromodulation Device Product Portfolio
- 8.3.5 General Stim (Nurotron) Recent Developments
- 8.4 Medtronic
- 8.4.1 Medtronic Company Information
- 8.4.2 Medtronic Business Overview
- 8.4.3 Medtronic Sacral Neuromodulation Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Medtronic Sacral Neuromodulation Device Product Portfolio
- 8.4.5 Medtronic Recent Developments
- 8.5 PINS Medical
- 8.5.1 PINS Medical Company Information
- 8.5.2 PINS Medical Business Overview
- 8.5.3 PINS Medical Sacral Neuromodulation Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 PINS Medical Sacral Neuromodulation Device Product Portfolio
- 8.5.5 PINS Medical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sacral Neuromodulation Device Value Chain Analysis
- 9.1.1 Sacral Neuromodulation Device Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sacral Neuromodulation Device Production Mode & Process
- 9.2 Sacral Neuromodulation Device Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sacral Neuromodulation Device Distributors
- 9.2.3 Sacral Neuromodulation Device Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst